Cargando…
Calreticulin is highly expressed in pancreatic cancer stem‐like cells
Cancer stem‐like cells (CSLCs) in solid tumors are thought to be resistant to conventional chemotherapy or molecular targeting therapy and to contribute to cancer recurrence and metastasis. In this study, we aimed to identify a biomarker of pancreatic CSLCs (P‐CSLCs). A P‐CSLC‐enriched population wa...
Autores principales: | Matsukuma, Satoshi, Yoshimura, Kiyoshi, Ueno, Tomio, Oga, Atsunori, Inoue, Moeko, Watanabe, Yusaku, Kuramasu, Atsuo, Fuse, Masanori, Tsunedomi, Ryouichi, Nagaoka, Satoshi, Eguchi, Hidetoshi, Matsui, Hiroto, Shindo, Yoshitaro, Maeda, Noriko, Tokuhisa, Yoshihiro, Kawano, Reo, Furuya‐Kondo, Tomoko, Itoh, Hiroshi, Yoshino, Shigefumi, Hazama, Shoichi, Oka, Masaaki, Nagano, Hiroaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5132278/ https://www.ncbi.nlm.nih.gov/pubmed/27561105 http://dx.doi.org/10.1111/cas.13061 |
Ejemplares similares
-
Cathepsin B is highly expressed in pancreatic cancer stem-like cells and is associated with patients' surgical outcomes
por: Fujimoto, Takuya, et al.
Publicado: (2021) -
Pancreatic Cancer Stem-Like Cells With High Calreticulin Expression Associated With Immune Surveillance
por: Fujiwara, Yasuhiro, et al.
Publicado: (2021) -
Expression levels of UL16 binding protein 1 and natural killer group 2 member D affect overall survival in patients with gastric cancer following gastrectomy
por: Kamei, Ryoji, et al.
Publicado: (2018) -
Novel Biomarkers for Personalized Cancer Immunotherapy
por: Shindo, Yoshitaro, et al.
Publicado: (2019) -
A stem cell medium containing neural stimulating factor induces a pancreatic cancer stem-like cell-enriched population
por: WATANABE, YUSAKU, et al.
Publicado: (2014)